Beyfortus approved in Singapore to protect all infants against RSV disease
Singapore’s Health Sciences Authority (HSA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab) for the prevention of respiratory …
The Heartbeat of World events
Singapore’s Health Sciences Authority (HSA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab) for the prevention of respiratory …